Clinical trial

Relationship of Haptoglobin Phenotype to Vascular Function and Response to Vitamin E Supplementation in Patients With Diabetes Mellitus Type 2: The EVAS Trial

NCT02776397

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2015-06-01

PhaseNA

Study timeline

Study start (unknown)2015-06-01Date precision: month

Registry last updated2016-05-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitusunresolved

Interventions

Vitamin EDIETARY_SUPPLEMENT

PlaceboOTHER

Sponsors & collaborators

Tan Tock Seng Hospitallead sponsor

Nanyang Technological Universitycollaborator

National Medical Research Council (NMRC), Singaporecollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02776397 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.